BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38366816)

  • 1. The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project.
    Carucci S; Zuddas A; Lampis A; Man KKC; Balia C; Buitelaar J; Danckaerts M; Dittmann RW; Donno F; Falissard B; Gagliano A; Garas P; Häge A; Hollis C; Inglis SK; Konrad K; Kovshoff H; Liddle E; McCarthy S; Neubert A; Nagy P; Rosenthal E; Sonuga-Barke EJS; Wong ICK; Banaschewski T; Coghill D
    J Atten Disord; 2024 Mar; 28(5):722-739. PubMed ID: 38366816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate and Sleep Difficulties in Children and Adolescents With ADHD: Results From the 2-Year Naturalistic Pharmacovigilance ADDUCE Study.
    Häge A; Man KKC; Inglis SK; Buitelaar J; Carucci S; Danckaerts M; Dittmann RW; Falissard B; Garas P; Hollis C; Konrad K; Kovshoff H; Liddle E; McCarthy S; Neubert A; Nagy P; Rosenthal E; Sonuga-Barke EJS; Zuddas A; Wong ICK; Coghill D; Banaschewski T
    J Atten Disord; 2024 Mar; 28(5):699-707. PubMed ID: 38389266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).
    McCarthy S; Neubert A; Man KKC; Banaschewski T; Buitelaar J; Carucci S; Coghill D; Danckaerts M; Falissard B; Garas P; Häge A; Hollis C; Inglis S; Kovshoff H; Liddle E; Mechler K; Nagy P; Rosenthal E; Schlack R; Sonuga-Barke E; Zuddas A; Wong ICK
    BMC Psychiatry; 2018 Oct; 18(1):327. PubMed ID: 30305167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
    Man KKC; Häge A; Banaschewski T; Inglis SK; Buitelaar J; Carucci S; Danckaerts M; Dittmann RW; Falissard B; Garas P; Hollis C; Konrad K; Kovshoff H; Liddle E; McCarthy S; Neubert A; Nagy P; Rosenthal E; Sonuga-Barke EJS; Zuddas A; Wong ICK; Coghill D;
    Lancet Psychiatry; 2023 May; 10(5):323-333. PubMed ID: 36958362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
    Inglis SK; Carucci S; Garas P; Häge A; Banaschewski T; Buitelaar JK; Dittmann RW; Falissard B; Hollis C; Kovshoff H; Liddle E; McCarthy S; Nagy P; Neubert A; Rosenthal E; Sonuga-Barke E; Wong I; Zuddas A; Coghill DC;
    BMJ Open; 2016 Apr; 6(4):e010433. PubMed ID: 27118284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder.
    Buitelaar JK; van de Loo-Neus GHH; Hennissen L; Greven CU; Hoekstra PJ; Nagy P; Ramos-Quiroga A; Rosenthal E; Kabir S; Man KKC; Ic W; Coghill D;
    Eur Neuropsychopharmacol; 2022 Nov; 64():63-71. PubMed ID: 36209558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate.
    Wolff N; Rubia K; Knopf H; Hölling H; Martini J; Ehrlich S; Roessner V
    Child Adolesc Psychiatry Ment Health; 2016; 10():24. PubMed ID: 27453723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
    Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
    CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status.
    Huang YS; Wang LJ; Chen CK
    BMC Psychiatry; 2012 Nov; 12():194. PubMed ID: 23140464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential disturbance of methylphenidate of gonadal hormones or pubescent development in patients with attention-deficit/hyperactivity disorder: A twelve-month follow-up study.
    Wang LJ; Huang YH; Chou WJ; Lee SY; Tsai CS; Lee MJ; Chou MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110181. PubMed ID: 33227299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study.
    Huss M; Poustka F; Lehmkuhl G; Lehmkuhl U
    J Neural Transm (Vienna); 2008; 115(2):335-9. PubMed ID: 18253808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
    Wilens T; Pelham W; Stein M; Conners CK; Abikoff H; Atkins M; August G; Greenhill L; McBurnett K; Palumbo D; Swanson J; Wolraich M
    J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):424-33. PubMed ID: 12649629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
    Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
    CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.
    Chou WJ; Chen SJ; Chen YS; Liang HY; Lin CC; Tang CS; Huang YS; Yeh CB; Chou MC; Lin DY; Hou PH; Wu YY; Liu HJ; Huang YF; Hwang KL; Chan CH; Pan CH; Chang HL; Huang CF; Hsu JW
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):215-25. PubMed ID: 22537358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
    Lam AP; Matthies S; Graf E; Colla M; Jacob C; Sobanski E; Alm B; Rösler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Müller HHO; Lücke C; Huss M; Jans T; Berger M; Tebartz van Elst L; Philipsen A;
    JAMA Netw Open; 2019 May; 2(5):e194980. PubMed ID: 31150084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population.
    Hodgkins P; Sasané R; Christensen L; Harley C; Liu F
    Curr Med Res Opin; 2011; 27 Suppl 2():53-62. PubMed ID: 21973231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate and atomoxetine treatment negatively affect physical growth indexes of school-age children and adolescents with attention-deficit/hyperactivity disorder.
    Deng L; Zhou P; Zhu L; Zhang Y; Yang T; Zhao Q; Chen J; Li T; Cheng Q; Chen L
    Pharmacol Biochem Behav; 2021 Sep; 208():173225. PubMed ID: 34217783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Methylphenidate on Reaction Time in Children with Attention Deficit / Hyperactivity Disorder.
    Güven A; Altinkaynak M; Dolu N; Demirci E; Özmen S; İzzetoğlu M; Pektaş F
    Noro Psikiyatr Ars; 2019 Mar; 56(1):27-31. PubMed ID: 30911234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of Proneness to Boredom in Children with Attention-Deficit/Hyperactivity Disorder On and Off Methylphenidate Treatment.
    Golubchik P; Manor I; Shoval G; Weizman A
    J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):173-176. PubMed ID: 32031873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.